Cordio Medical Raises $18M in Funding
- Cordio Medical, a NYC-based medical speech processing platform provider, raised $18m in funding
- Backers included Ceros Capital Markets, the investment banking division of Ceros Financial Services, and Peregrine Ventures
- The company intends to use the funds to support clinical studies, partnerships, operations, and R&D
- CordioMedical develops and provides solutions for monitoring health conditions through a patient’s speech
- Its technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities
- A patient speaks into a smartphone app backed by proprietary algorithms that allow near real-time monitoring and early detection of condition deterioration
